National Association of Testing Authorities, Australia
Scope of Accreditation
Women's and Children's Pathology - The Royal Children's Hospital
Site
The Royal Children’s Hospital
Accreditation No.
2555
Site No.
2548
Date of Accreditation
27 Jan 1989
Contact
Ms Anthea O'Brien P: +61 (03) 93454386
Availability
Services available to external clients
Supervision
GX (General)
Scope of Accreditation
Anatomical Pathology
ISO 15189 (2022)
- This facility complies with the relevant National Pathology Accreditation Advisory Council (NPAAC) requirements.
Human Pathology
Medicare expiry date
19 Sep 2028
Last Activity Date
21 Mar 2024
| Service | Product | Determinant |
|---|---|---|
| Anatomical pathology - Cytopathology - Non-gynaecological cytological investigations of body fluids, exudates, washings and brushings from non-squamous mucosal sites for the detection of malignancy | Cerebrospinal fluid (CSF); Ocular specimens; Other body fluids; Sputum; Urine; Vitreous specimens; Washings or brushings from other sites | Cytological examination; Review and reporting of cytology samples |
| Anatomical pathology - Tissue pathology - Examination of biopsy material | Formalin-fixed tissue | Review and reporting of biopsy material to identify or exclude morphological abnormalities |
| Anatomical pathology - Tissue pathology - Examination of biopsy material by electron microscopy | Fluids; Formalin-fixed tissue; Fresh tissue; Gluteraldehyde tissue; Nasal brushings | Review and reporting of biopsy material to identify or exclude ultra-structural morphological abnormalities |
| Anatomical pathology - Tissue pathology - Gene probes using paraffin in situ hybridisation techniques (chromogenic/silver) | Formalin-fixed paraffin-embedded (FFPE) tissues | Detection of nucleic acid targets - Various |
| Anatomical pathology - Tissue pathology - Immediate frozen section diagnosis | Fresh tissue | Intra-operative consultation and examination of biopsy material |
| Anatomical pathology - Tissue pathology - Immunohistochemical (immunofluorescence) investigation | Fresh tissue; Frozen tissue | Detection of antigenic targets - Various |
| Anatomical pathology - Tissue pathology - Immunohistochemical investigation | Formalin-fixed paraffin-embedded (FFPE) tissues | Detection of antigenic targets - Various |
| Molecular genetics - RNA extraction | Formalin-fixed paraffin-embedded (FFPE) tissues | Viable RNA |
| Molecular genetics - Screening for an unknown mutation - Targeted panels for non-inherited (somatic) DNA/RNA changes | Extracted RNA; Formalin-fixed paraffin-embedded (FFPE) tissues | Fusion genes; Medulloblastoma subtyping |
Cardiac Theatre
ISO 15189 (2022)
Human Pathology
Medicare expiry date
19 Sep 2028
Last Activity Date
21 Mar 2024
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Base excess; Bicarbonate; Calcium - Ionised; Chloride; Deoxyhaemoglobin (HHb); Glucose; Haemoglobin (Hb); Lactate; Methaemoglobin (MetHb); Oxygen saturation (sO2); Oxyhaemoglobin; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; pH |
Cell Therapies and Flow Cytometry
ISO 15189 (2022)
Human Pathology
Medicare expiry date
19 Sep 2028
Last Activity Date
21 Mar 2024
| Service | Product | Determinant |
|---|---|---|
| Haematology - Foetal haemoglobin in maternal circulation | Blood | Detection and quantitation of foetal red cells |
| Haematology - Full blood examination | Blood | Differential number; Erythrocyte count (red blood cell count, RBCC); Haematocrit (packed cell volume, PCV); Haemoglobin (Hb); Leucocyte count (white blood cell count, WBCC); Platelet count; Red blood cell distribution width (RDW); Red blood cell index or indices |
| Bone marrow | Differential number; Erythrocyte count (red blood cell count, RBCC); Haematocrit (packed cell volume, PCV); Leucocyte count (white blood cell count, WBCC); Platelet count | |
| Cord blood | Leucocyte count (white blood cell count, WBCC) | |
| Haemopoietic progenitor cells | Differential number; Erythrocyte count (red blood cell count, RBCC); Leucocyte count (white blood cell count, WBCC); Platelet count | |
| Immunopathology - Characterisation of leucocyte surface antigens (including immunophenotyping) | Blood | 7-Aminoactinomycin (7-AAD); CD34; CD45 |
| Eosin-5-maleimide | ||
| Blood; Bone marrow; Cerebrospinal fluid (CSF); Disaggregated tissues specimen | CD10; CD117; CD11b; CD123; CD13; CD14; CD15; CD16; CD19; CD1a; CD2; CD20; CD22; CD235a; CD24; CD3; CD30; CD300e (IREM-2); CD33; CD34; CD35; CD36; CD38; CD4; CD41; CD45; CD48; CD5; CD56; CD58; CD61; CD64; CD66b; CD7; CD71; CD8; CD9; Cytoplasmic terminal deoxynucleotidyl transferase (cTdT); HLA-DR antigen; Kappa light chains; Lambda light chains; cCD3; cCD79a; cMPO | |
| Blood; Bone marrow; Disaggregated tissues specimen; Formalin-fixed paraffin-embedded (FFPE) tissues | DNA index | |
| Immunopathology - Procedures related to the collection, processing, storage and issue of human haemopoietic progenitor cells | Haemopoietic progenitor cells | Clonogenic assays (culture) of harvested bone marrow/peripheral blood progenitor cells/cord blood stem cells |
| Enumeration of CD19+ cells; Enumeration of CD3+ cells; Enumeration of CD4+ cells; Enumeration of CD8+ cells | ||
| Immunopathology - Procedures related to the collection, processing, storage and issue of human haemopoietic progenitor cellsProducts received from 17310-19012 | Haemopoietic progenitor cells | Processing; Storage (includes freezing/thawing) |
Chemical Pathology
ISO 15189 (2022)
Human Pathology
Medicare expiry date
19 Sep 2028
Last Activity Date
21 Mar 2024
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Analysis of drugs for toxicological (non-legal) purposes and ingested or absorbed toxic chemicals | Urine | Amphetamines; Barbiturates; Benzodiazepines; Cannabis; Cocaine; Opiates |
| Chemical pathology - Biogenic amines | Urine | 5-Hydroxyindoleacetic acid (5-HIAA); Adrenaline; Dopamine; Homovanillic acid (HVA); Noradrenaline |
| Chemical pathology - Detection and/or quantitation of drugs for therapeutic monitoring | Blood | Cyclosporin; Methotrexate; Tacrolimus |
| Plasma; Serum | Carbamazepine; Digoxin; Gentamicin (cidomycin, septopal, genticyn, garamycin); Paracetamol (acetaminophen); Phenytoin (dilantin); Theophylline; Tobramycin; Valproate (valproic acid, epilim); Vancomycin | |
| Phenobarbitone | ||
| Amikacin | ||
| Chemical pathology - Detection and/or quantitation of tumour markers | Plasma; Serum | Human chorionic gonadotropin (hCG) |
| Chemical pathology - Detection of faecal occult blood | Faeces | Blood |
| Chemical pathology - Determination of hormones and hormone binding proteins (other than thyroid function tests) | Plasma; Serum | Androstenedione |
| 17α-Hydroxyprogesterone | ||
| Insulin-like growth factor 1 (IGF-1, somatomedin C); Insulin-like growth factor-binding protein 3 (IGF-BP3) | ||
| Adrenocorticotropic hormone (ACTH); Anti-Mullerian hormone (AMH); Dehydroepiandrosterone sulfate (DHEAS); Growth hormone; Insulin; Oestradiol; Parathyroid hormone (PTH); Procalcitonin; Sex hormone binding globulin (SHBG); Testosterone | ||
| Plasma; Serum; Urine | Cortisol | |
| Urine | Urine steroid fraction(s) | |
| Chemical pathology - Diagnosis and management of diabetes mellitus | Blood | Glycated haemoglobin (HbA1c) |
| Chemical pathology - Dynamic tests | Sweat | Sweat chloride |
| Chemical pathology - Further investigation of cardiac function | Plasma; Serum | Troponin |
| Chemical pathology - Further investigation of renal and/or hepatic function | Plasma; Serum | Caeruloplasmin; Haptoglobins |
| Bile acids - Quantitative | ||
| Chemical pathology - Investigation and determination of hepatic, cardiac, bone, skeletal muscle and other profiles and metabolic studies | Cerebrospinal fluid (CSF) | Glucose; Lactate; Protein - Total |
| Plasma; Serum | Alanine aminotransferase; Albumin; Alkaline phosphatase; Ammonia; Amylase; Aspartate aminotransferase; Bicarbonate; Bilirubin - Any fractions; Bilirubin - Total; C-reactive protein (CRP); Calcium - Total; Chloride; Cholesterol - HDL; Cholesterol - LDL; Cholesterol - Total; Creatine kinase; Creatinine; Glucose; Lactate; Lactate dehydrogenase (LDH); Lipase; Magnesium; Phosphate; Potassium; Protein - Total; Sodium; Triglycerides; Urea; Uric acid; γ-Glutamyltransferase | |
| Plasma; Serum; Urine | Osmolality | |
| Urine | Albumin; Calcium - Total; Chloride; Creatinine; Glucose; Lactate; Magnesium; Phosphate; Potassium; Protein - Total; Sodium; Urea; Uric acid | |
| Chemical pathology - Investigation for folate deficiency | Blood | Red blood cell folate |
| Chemical pathology - Investigation of malabsorption | Faeces | Reducing substances |
| Chemical pathology - Investigation of malabsorption - Quantitation of solid tissue enzymes | Intestinal tissue | Glucose; Isomaltase; Lactase; Maltase; Protein - Microsomal triglyceride transfer (MTP); Sucrase |
| Glucose; Isomaltase; Lactase; Maltase; Protein - Microsomal triglyceride transfer (MTP); Sucrase | ||
| Chemical pathology - Investigation of maternal markers for pre-eclampsia | Plasma; Serum | Placental growth factor (PGF, PLGF); sFlt-1/PlGF ratio |
| Chemical pathology - Iron studies | Plasma; Serum | Ferritin; Iron; Transferrin |
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Base excess; Bicarbonate; Calcium - Ionised; Carboxyhaemoglobin; Chloride; Deoxyhaemoglobin (HHb); Glucose; Haemoglobin (Hb); Lactate; Methaemoglobin (MetHb); Oxygen saturation (sO2); Oxyhaemoglobin; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; pH |
| Chemical pathology - Quantitation of precursor and intermediary metabolites | Plasma; Serum | Homocysteine |
| Chemical pathology - Quantitation of vitamin B markers | Blood | Holotranscobalamin (active vitamin B12) |
| Chemical pathology - Quantitation of vitamins | Plasma; Serum | Retinol (vitamin A); Tocopherol (vitamin E) |
| 25-Hydroxyvitamin D | ||
| Chemical pathology - Tests for thyroid function | Plasma; Serum | Thyroid stimulating hormone (TSH); Thyroxine (T4) - Free; Triiodothyronine (T3) - Free |
| Chemical pathology - Trace element analysis | Plasma; Serum | Zinc |
| Plasma; Serum; Urine | Copper | |
| Copper | ||
| Haematology - Assessment of haemolysis or metabolic enzymes (red cell enzyme assays) | Blood | Glucose-6-phosphate dehydrogenase (G6PD) |
| Immunopathology - Detection and/or quantitation and/or characterisation of autoantibodies | Plasma; Serum | Anti-tyrosine hydroxylase antibodies (Th/To) |
| Rheumatoid factor | ||
| Anti-thyroid antibodies | ||
| Serum | Anti-thyroglobulin antibodies (Tg); Anti-thyroid peroxidase antibodies (TPO) | |
| Immunopathology - Quantitation of complement proteins | Plasma; Serum | Complement components C3 and C4 |
| Immunopathology - Quantitative and/or qualitative investigation of proteins | Plasma; Serum | α1-Antitrypsin |
| Immunopathology - Quantitative investigations of immunoglobulins and immunoglobulins subclasses | Plasma; Serum | Total immunoglobulin A; Total immunoglobulin G; Total immunoglobulin M |
| Infertility and pregnancy tests including assisted reproductive technology - Diagnosis or follow up of threatened abortion and/or diagnosis of ectopic pregnancy | Plasma; Serum | Human chorionic gonadotropin (hCG) - Quantitative total |
Emergency Department
ISO 15189 (2022)
Human Pathology
Medicare expiry date
19 Sep 2028
Last Activity Date
21 Mar 2024
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Base excess; Bicarbonate; Calcium - Ionised; Chloride; Deoxyhaemoglobin (HHb); Glucose; Haemoglobin (Hb); Lactate; Methaemoglobin (MetHb); Oxygen saturation (sO2); Oxyhaemoglobin; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; pH |
General Theatre
ISO 15189 (2022)
Human Pathology
Medicare expiry date
19 Sep 2028
Last Activity Date
21 Mar 2024
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Base excess; Bicarbonate; Calcium - Ionised; Chloride; Deoxyhaemoglobin (HHb); Glucose; Haemoglobin (Hb); Lactate; Methaemoglobin (MetHb); Oxygen saturation (sO2); Oxyhaemoglobin; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; pH |
Haematology
ISO 15189 (2022)
Human Pathology
Medicare expiry date
19 Sep 2028
Last Activity Date
21 Mar 2024
| Service | Product | Determinant |
|---|---|---|
| Haematology - Bone marrow examination | Bone marrow | Examination of aspirated material |
| Haematology - Diagnosis of thalassemia | Blood | Haemoglobin A2 (HbA2) - Quantitation; Haemoglobin F (HbF) - Quantitation |
| Haemoglobin A2 (HbA2) - Quantitation; Haemoglobin F (HbF) - Quantitation | ||
| Haematology - Examination of blood films by special staining | Blood | Malaria |
| Haematology - Foetal haemoglobin in maternal circulation | Blood | Detection and quantitation of foetal red cells |
| Haematology - Full blood examination | Blood | Differential number; Erythrocyte count (red blood cell count, RBCC); Haematocrit (packed cell volume, PCV); Haemoglobin (Hb); Leucocyte count (white blood cell count, WBCC); Platelet count; Red blood cell distribution width (RDW); Red blood cell index or indices; Reticulocytes |
| Differential number; Morphology; Reticulocytes | ||
| Cerebrospinal fluid (CSF); Fluids | Erythrocyte count (red blood cell count, RBCC); Leucocyte count (white blood cell count, WBCC) | |
| Erythrocyte count (red blood cell count, RBCC); Leucocyte count (white blood cell count, WBCC) | ||
| Haematology - Haemostasis related analysis (including special coagulation testing and platelet function tests) | Blood | Platelet function (PFA) |
| Plasma | Factor XIII | |
| Activated partial thromboplastin time (APTT); Activated protein C (APC) resistance; Anti-Xa activity - Clexane - Low molecular weight heparin; Anti-Xa activity - Fragmin - Low molecular weight heparin; Anti-Xa activity - Unfractionated heparin; Anti-thrombin III; D-dimer; Factor II; Factor IX; Factor IX inhibitor; Factor V; Factor VII; Factor VIII; Factor VIII inhibitor; Factor X; Factor XI; Factor XII; Fibrinogen; International normalised ratio (INR); Lupus anticoagulant; Protein C and protein S; Prothrombin time (PT); Reptilase time; Thrombin time (TT); Von Willebrand collagen binding assay; Von Willebrand factor (vWF); Von Willebrand factor (vWF) activity - Ristocetin co-factor assay | ||
| Von Willebrand collagen binding assay | ||
| Haematology - Investigation of haemoglobinopathy (excluding thalassemia) | Blood | Haemoglobin fraction (S, C, D, E) - Quantitation; Other abnormal haemoglobins |
| Haemoglobin S (HbS) - Presence | ||
| Haematology - Limited blood examination | Blood | Erythrocyte (RBC) sedimentation rate (ESR) |
| Immunohaematology - Blood group antibody detection | Blood | Other blood group systems |
| Immunohaematology - Blood grouping | Blood | ABO; RhD |
| Immunohaematology - Determination of compatibility of blood donor units | Blood | Examination for blood group antibodies; Group checks of patient and donor; Identification of detected antibodies |
| Immunohaematology - Identification and quantitation of blood group antibodies | Blood | Antibody elution |
| Red blood cell phenotyping | ||
| Antibody absorption; Direct antiglobulin test (DAT, direct Coombs test) | ||
| Antibody titration | ||
| Immunohaematology - Investigation of blood transfusion reactions | Blood products | Antibodies; Contamination - Microbiological; Direct antiglobulin test (DAT, direct Coombs test); Examination for blood group antibodies; Group checks of patient and donor; Identification of detected antibodies |
| Immunohaematology - Issue and release of blood and blood product for transfusion | Blood; Blood products; Cryoprecipitate; Fresh frozen plasma (FFP); Platelets | Issue and release of blood and blood products for transfusion |
| Immunohaematology - Storage and distribution of blood and blood components | Blood; Blood products; Cryoprecipitate; Fresh frozen plasma (FFP); Platelets | Issue and release of blood and blood products for transfusion |
| Microbiology - Parasitology - Detection of ova, cysts and parasites | Blood | Malaria |
| Microbiology - Serology of infection - Microbial antibody and/or antigen detection and/or quantitation | Blood; Plasma; Serum | Infectious mononucleosis |
Immunopathology
ISO 15189 (2022)
Human Pathology
Medicare expiry date
19 Sep 2028
Last Activity Date
21 Mar 2024
| Service | Product | Determinant |
|---|---|---|
| Immunopathology - Characterisation of leucocyte surface antigens (including immunophenotyping) | Blood | B-cell; CD10; CD16; CD18; CD19; CD21; CD27; CD3; CD4; CD40; CD40 ligand; CD45; CD45RA; CD45RO; CD46; CD56; CD62L; CD8; Dock 8; Double negative T-cells; HLA-DR antigen; Ki-67 antigen; Leucocyte adhesion deficiency (LAD) screening; Lipopolysaccharide-responsive beige-like anchor (LRBA); Memory B cell subsets; Memory T cell subsets; Memory cells; Naive B cells; Naive T-cells; Natural killer (NK) cells; Perforin; Signalling lymphocytic activation molecule (SLAM)-associated protein (SAP); Stat1 phosphorylation; Stat3 phosphorylation; Stat4 phosphorylation; Stat5 phosphorylation; T follicular helper cells; T reg cells; T-cell receptor aβ (TCRab); T-cell receptor γδ (TCRgd); T-cells; TH17; X-linked inhibitor of apoptosis protein (XIAP) |
| Immunopathology - Detection and/or quantitation and/or characterisation of autoantibodies | Plasma; Serum | Anti-interferon alpha autoantibodies; Anti-interferon gamma autoantibodies; Anti-interferon omega autoantibodies |
| Complement factor H antibodies | ||
| Serum | Anti-β2-glycoprotein-I antibodies | |
| Anti-zinc transporter protein 8 antibodies (ZNT8) | ||
| Anti-double stranded DNA antibodies (dsDNA) | ||
| Anti-cardiolipin antibodies (ACA); Anti-deamidated gliadin antibodies | ||
| Anti-nuclear antibodies (ANA) | ||
| Anti-extractable nuclear antigen antibodies (ENA); Anti-tissue transglutaminase antibodies (tTG) | ||
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential component testing [purified native and/or recombinant allergens]) | Serum | Ara h2 - Peanut |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential drug allergens) | Serum | Amoxicilloyl group; Ampicilloyl group; Penicilloyl G; Penicilloyl V |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential epidermal and animal protein allergens) | Serum | Cat epithelium; Dog epithelium; Epithelial mix; Horse epithelium |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [egg and fowl] allergens) | Serum | Egg white |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [fish, shellfish and molluscs] allergens) | Serum | Codfish; Crab; Salmon; Shrimp |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [fruit and vegetable] allergens) | Serum | Banana; Carrot; Kiwi |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [milk] allergens) | Serum | Cow milk |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [seeds, legumes and nuts] allergens) | Serum | Almond; Buck wheat; Cashew nut; Chick pea; Hazelnut; Lupin seed; Macadamia nut; Oat; Peanut; Pecan nut; Pinenut; Pistachio; Rice; Sesame seed; Soy bean; Walnut; Wheat |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential grass pollen allergens) | Serum | Bahia grass; Bermuda grass; Grass mix; Rye grass |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential microorganism allergens) | Serum | Aspergillus fumigatus; Mould mix |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential mite allergens) | Serum | Dermatophagoides pteronyssinus house dust mite |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential occupational allergens) | Serum | Latex |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential tree pollen allergens) | Serum | Acacia; Cypress; Recombinant birch; Tree mix |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential venom allergens) | Serum | Bee venom; Common wasp (yellow jacket) venom; Paper wasp venom |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential weed pollen allergens) | Serum | Plantain - English |
| Immunopathology - Investigation and/or assessment of neutrophils - Functional tests | Blood | Phagocytosis; Qualitative assessment of neutrophils for the presence of oxidative pathway defects; Quantitative assessment of oxidative pathways |
| Immunopathology - Investigation of natural killer cell release from target cells | Blood | Natural killer (NK) cell cytotoxicity; Natural killer (NK) cell degranulation; Natural killer (NK) cell number |
| Immunopathology - Quantitation of complement proteins | Plasma; Serum | Complement function screening test |
| Immunopathology - Quantitative and/or qualitative investigation of proteins | Faeces | Calprotectin |
| Plasma; Serum | CD25 - Soluble | |
| Immunopathology - Quantitative investigations of immunoglobulins and immunoglobulins subclasses | Serum | Total immunoglobulin E |
| Immunopathology - Tests of cellular immunity - Lymphocyte function tests | Blood | Lymphocyte function; Proliferation by antigens; Proliferation by mitogens; Sep-anti CD3; Sep-candida; Sep-phytohemagglutinin (PHA) |
| Microbiology - Serology of infection - Microbial antibody and/or antigen detection and/or quantitation | Serum | Tetanus IgG antibody |
| Streptococcus pneumoniae IgG antibody |
Microbiology
ISO 15189 (2022)
Human Pathology
Medicare expiry date
19 Sep 2028
Last Activity Date
21 Mar 2024
| Service | Product | Determinant |
|---|---|---|
| Microbiology - Bacteriology - Detection of pathogenic bacteria | Blood | Bacteria; Pathogenic microorganisms |
| Blood; Cerebrospinal fluid (CSF); Faeces; Fluids; General swabs; Genital swabs; Pus; Respiratory specimens; Urine; Wound swabs | Bacteria; Pathogenic identification and antibiotic susceptibility | |
| Bacteria; Pathogenic identification and antibiotic susceptibility | ||
| Bacteria; Pathogenic identification and antibiotic susceptibility | ||
| Bacteria; Pathogenic microorganisms | ||
| Blood; Cerebrospinal fluid (CSF); General swabs; Genital swabs; Pus; Respiratory specimens; Wound swabs | Bacteria; Epithelial cells; Erythrocytes (red blood cells, RBC); Leucocytes (white blood cells, WBC) | |
| Cerebrospinal fluid (CSF) | Erythrocytes (red blood cells, RBC); Leucocytes (white blood cells, WBC) | |
| Faeces | Clostridium difficile glutamate dehydrogenase | |
| Urine | Glucose; Haemoglobin (Hb); Ketones; Leucocytes (white blood cells, WBC); Nitrite; Proteins; pH | |
| Bacteria; Casts; Crystals; Epithelial cells; Erythrocytes (red blood cells, RBC); Leucocytes (white blood cells, WBC) | ||
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (bacteria) | Cerebrospinal fluid (CSF) | Escherichia coli K1; Haemophilus influenzae; Listeria monocytogenes; Neisseria meningitidis; Streptococcus agalactiae (Streptococcus group B); Streptococcus pneumoniae |
| Faeces | Clostridioides difficile | |
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (fungi) | Cerebrospinal fluid (CSF) | Cryptococcus gattii; Cryptococcus neoformans |
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (mycobacteria) | Bronchoalveolar lavage; Pus; Tissues | Mycobacterium tuberculosis; Mycobacterium rifampicin resistance rpoB |
| Sputum | Mycobacterium tuberculosis; Mycobacterium rifampicin resistance rpoB | |
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (viruses) | Cerebrospinal fluid (CSF) | Cytomegalovirus (CMV); Enterovirus; Herpes simplex virus type 1 (HSV1); Herpes simplex virus type 2 (HSV2); Human parechovirus; Varicella zoster virus (VZV) |
| Cytomegalovirus (CMV); Enterovirus; Herpes simplex virus type 1 (HSV1); Herpes simplex virus type 2 (HSV2); Human parechovirus; Varicella zoster virus (VZV) | ||
| Faeces | Norovirus | |
| Nasal aspirates/washes; Nasopharyngeal swabs | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) | |
| Nasal swabs; Nasopharyngeal swabs | Influenza A virus; Influenza B virus; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) | |
| Microbiology - Mycobacteriology - Detection and identification of mycobacteria | Other body fluids; Respiratory specimens; Tissues | Mycobacteria identification |
| Microbiology - Mycobacteriology - Tests for antigen lymphocyte stimulation | Blood; Plasma | Mycobacterial antigen lymphocyte stimulation |
| Microbiology - Mycology - Detection, isolation and/or identification of yeasts and/or fungal elements | Hair; Nails; Skin scrapings | Fungi identification; Yeasts identification |
| Fungi identification; Yeasts identification | ||
| Yeast susceptibility | ||
| Microbiology - Parasitology - Detection of ova, cysts and parasites | Faeces | Cysts; Ova; Parasites |
Microbiology and Infectious Diseases
ISO 15189 (2022)
- This facility complies with the relevant National Pathology Accreditation Advisory Council (NPAAC) requirements.
Human Pathology
Medicare expiry date
19 Sep 2028
Last Activity Date
21 Mar 2024
| Service | Product | Determinant |
|---|---|---|
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (bacteria) | Amniotic fluid; Blood; Cerebrospinal fluid (CSF); Plasma; Serum; Tissues | Toxoplasma gondii |
| Bacterial isolates | Pan-bacterial 16s | |
| Bacterial isolates; Dry swabs; Tampons; Urine | Neisseria gonorrhoeae | |
| Blood; Dry swabs; Nasopharyngeal swabs; Sputum | Chlamydophila pneumoniae | |
| Bronchial washings; Bronchoalveolar lavage; Dry swabs; Nasopharyngeal aspirate; Nasopharyngeal swabs; Sputum | Bordetella pertussis; Mycoplasma pneumoniae | |
| Cervical swabs; Liquid based swabs; Oropharyngeal swabs; Rectal swabs; Urethral swabs; Urine; Vaginal swabs | Mycoplasma genitalium | |
| Dry swabs; Liquid based swabs; Urine | Ureaplasma parvum; Ureaplasma urealyticum | |
| Dry swabs; Semen; Urine | Chlamydia trachomatis; Neisseria gonorrhoeae | |
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (fungi) | Bacterial isolates | Panfungal 18s |
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (protozoan parasites) | Dry swabs; Liquid based swabs; Urine | Trichomonas vaginalis |
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (viruses) | Amniotic fluid; Blood; Bronchial washings; Bronchoalveolar lavage; Dry swabs; Faeces; Nasopharyngeal aspirate; Nasopharyngeal swabs; Plasma; Serum; Sputum; Tissues; Urine | Adenovirus |
| Amniotic fluid; Blood; Cerebrospinal fluid (CSF); Dried blood spots; Dry swabs; Faeces; Plasma; Semen; Serum; Tissues; Urine | Cytomegalovirus (CMV) | |
| Amniotic fluid; Blood; Cerebrospinal fluid (CSF); Dry swabs; Liquid based swabs; Plasma; Serum; Tissues | Varicella zoster virus (VZV) | |
| Amniotic fluid; Blood; Plasma; Serum; Tissues | Parvovirus B19 | |
| Blood; Cerebrospinal fluid (CSF); Dry swabs; Plasma; Semen; Serum | Herpes simplex virus (HSV) | |
| Blood; Cerebrospinal fluid (CSF); Plasma; Serum; Urine | BK virus; John Cunningham virus (JC) | |
| Blood; Dry swabs; Faeces; Nasopharyngeal aspirate; Plasma; Serum; Sputum; Tissues; Urine | Enterovirus | |
| Blood; Plasma; Serum | Human herpes virus type 6 (HHV6) | |
| Epstein-Barr virus | ||
| Bronchial washings; Bronchoalveolar lavage; Dry swabs; Nasopharyngeal aspirate; Nasopharyngeal swabs; Sputum | Adenovirus group E; Enterovirus; Human metapneumovirus; Human parechovirus; Influenza A virus; Influenza A virus H1; Influenza A virus H3; Influenza A virus H3N2; Influenza A virus H5; Influenza A virus H7 - 2013 China strain; Influenza B virus; Influenza B virus - Victoria lineage; Influenza B virus - Yamagata lineage; Parainfluenza virus type 1/2/3/4; Parechovirus; Respiratory syncytial virus (RSV) A/B; Respiratory syncytial virus (RSV); Rhinovirus; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) | |
| Bronchoalveolar lavage; Nasopharyngeal aspirate; Nasopharyngeal swabs; Sputum; Throat swabs | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) | |
| Cerebrospinal fluid (CSF); Dry swabs; Tissues | Epstein-Barr virus | |
| Dry swabs; Liquid based cytology specimens; Paraffin embedded tissue; Tampons; Tissues | Human papilloma virus (HPV) | |
| Endotrachael aspirate; Nasal swabs; Nasopharyngeal aspirate; Nasopharyngeal swabs; Sputum; Throat swabs; Tissue culture | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) | |
| Flocked saliva swabs | Influenza A virus; Influenza B virus; Respiratory syncytial virus (RSV); Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) | |
| Liquid based swabs | Adenovirus; Cytomegalovirus (CMV); Enterovirus; Herpes simplex virus type 1 (HSV1); Herpes simplex virus type 2 (HSV2); Varicella zoster virus (VZV) | |
| Microbiology - Molecular biology - Microbial genotyping | Dry swabs; Fresh biopsy; Liquid based cytology specimens; Paraffin embedded tissue; Tampons | Human papilloma virus (HPV) |
NICU
ISO 15189 (2022)
Human Pathology
Medicare expiry date
19 Sep 2028
Last Activity Date
21 Mar 2024
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Base excess; Bicarbonate; Calcium - Ionised; Chloride; Deoxyhaemoglobin (HHb); Glucose; Haemoglobin (Hb); Lactate; Methaemoglobin (MetHb); Oxygen saturation (sO2); Oxyhaemoglobin; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; pH |
Outpatients Pathology Collection
ISO 15189 (2022)
Human Pathology
Medicare expiry date
19 Sep 2028
Last Activity Date
21 Mar 2024
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Investigation of Helicobacter pylori colonisation or eradication | Breath | Hydrogen |
| Haematology - Haemostasis related analysis (including special coagulation testing and platelet function tests) | Blood | International normalised ratio (INR); Prothrombin time (PT) |
Paediatric Intensive Care Unit
ISO 15189 (2022)
Human Pathology
Medicare expiry date
19 Sep 2028
Last Activity Date
21 Mar 2024
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Base excess; Bicarbonate; Calcium - Ionised; Chloride; Deoxyhaemoglobin (HHb); Glucose; Haemoglobin (Hb); Lactate; Methaemoglobin (MetHb); Oxygen saturation (sO2); Oxyhaemoglobin; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; pH |
Serology
ISO 15189 (2022)
Human Pathology
Medicare expiry date
19 Sep 2028
Last Activity Date
21 Mar 2024
| Service | Product | Determinant |
|---|---|---|
| Microbiology - Serology of infection - Microbial antibody and/or antigen detection and/or quantitation | Faeces | Rotavirus antigen |
| Plasma; Serum | Syphilis Treponema pallidum antibody | |
| Bordetella pertussis IgA; Bordetella pertussis IgG; Chlamydia spp.; Cytomegalovirus antibody (anti-CMV) IgG; Cytomegalovirus antibody (anti-CMV) IgM; Epstein-Barr virus nuclear antigen IgG antibody; Epstein-Barr virus viral capsid antigen IgG antibody; Epstein-Barr virus viral capsid antigen IgM antibody; Hepatitis A virus antibody (anti-HAV) - IgM; Hepatitis A virus antibody (anti-HAV) - Total; Hepatitis B virus core antibody (anti-HBc) - Total; Hepatitis B virus surface antibody (anti-HBs); Hepatitis B virus surface antigen (HBs Ag); Hepatitis C virus (HCV); Herpes simplex virus type 2 antibody (anti-HSV2) - IgG; Herpes simplex type 1 antibody (anti-HSV1) - IgG; Histoplasma precipitins; Human immunodeficiency virus (HIV); Influenza A virus; Measles IgG antibody; Measles IgM antibody; Mumps virus IgG antibody; Mumps virus IgM antibody; Mycoplasma pneumoniae IgG antibody; Mycoplasma pneumoniae IgM antibody; Parvovirus IgG antibody; Parvovirus IgM antibody; Rubella IgG antibody; Rubella IgM antibody; Syphilis Treponema pallidum antibody; Toxoplasma spp. IgG antibody; Toxoplasma spp. IgM antibody; Varicella zoster virus (VZV) IgG antibody; Varicella zoster virus IgM antibody | ||
| Anti-streptolysin O (ASOT) | ||
| Syphilis Treponema pallidum antibody | ||
| Cytomegalovirus (CMV); Hepatitis B virus surface antigen (HBs Ag); Hepatitis C virus (HCV); Measles IgG antibody; Rubella IgM antibody; Toxoplasma spp. IgM antibody; Varicella zoster virus (VZV) IgG antibody |
The only data displayed is that deemed relevant and necessary for the clear description of the activities and services covered by the scope of accreditation.
Grey text appearing in a SoA is additional freetext providing further refinement or information on the data in the preceding line entry.
Accreditation No.
2555
Site No.
2548
Print date
15 Jan 2025
END OF SCOPE